Advertisement

Infection control: beyond the horizon

Published:December 13, 2014DOI:https://doi.org/10.1016/j.jhin.2014.11.004

      Summary

      This article will consider possible future directions for innovation and research in infection prevention and control, and will make the case for the importance of including clinical and cost-effectiveness evaluation in such research. Opportunities for studies in a number of broad subject areas will be considered, including prevention and control of existing and emerging infection hazards, the challenges posed by changes in the way that medical care is being delivered, technological developments that could be harnessed for infection prevention and control, how new laboratory diagnostic technologies might benefit infection prevention and control, cleaning and decontamination, and the infection control aspects of hospital design. The need for robust economic data to support the wide and timely implementation of evidence-based practice is emphasized.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zimlichman E.
        • Henderson D.
        • Tamir O.
        • et al.
        Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.
        JAMA Intern Med. 2013; 173: 2039-2046
        • Liebowitz L.D.
        MRSA burden and interventions.
        Int J Antimicrob Agents. 2009; 34: S11-S13
        • Public Health England
        Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae.
        PHE, LondonDecember 2013
        • Kelly T.
        • Yang W.
        • Chen C.S.
        • Reynolds K.
        • He J.
        Global burden of obesity in 2005 and projections to 2030.
        Int J Obes (Lond). 2008; 32: 1431-1437
        • Huttunen R.
        • Syrjänen J.
        Obesity and the risk and outcome of infection.
        Int J Obes (Lond). 2013; 37: 333-340
        • Office for National Statistics
        Historic and projected mortality data from the period and cohort life tables, 2012-based, UK, 1981‒2062.
        ONS, London11 December 2013
        • Ekeland A.G.
        • Bowes A.
        • Flottorp S.
        Effectiveness of telemedicine: a systematic review of reviews.
        Int J Med Inform. 2010; 79: 736-771
        • Sabat A.J.
        • Budimir A.
        • Nashev D.
        • et al.
        Overview of molecular typing methods for outbreak detection and epidemiological surveillance.
        Euro Surveill. 2013; 18: 20380
        • O’Connor N.
        • Cahill O.
        • Daniels S.
        • Galvin S.
        • Humphreys H.
        Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections?.
        J Hosp Infect. 2014; 88: 59-65
        • Graves N.
        • Harbarth S.
        • Beyersmann J.
        • Barnett A.
        • Halton K.
        • Cooper B.
        Estimating the cost of health care-associated infections: mind your p’s and q’s.
        Clin Infect Dis. 2010; 50: 1017-1021